ST PAUL, Minn. — The Office of Medical Cannabis within the Minnesota Department of Health is now accepting written public comments on petitions for three new potential qualifying conditions under Minnesota's Medical Cannabis Program:
- Sickle cell disease
- Tic disorder
A Medical Cannabis Review Panel will consider all public comments, as well as scientific reviews, and report to the Commissioner of Health by November. Health Commissioner Jan Malcolm will then accept or deny the petitions by Dec. 1.
Comments can be submitted by emailing the Office of Medical Cannabis at email@example.com, or mailed to this address:
Office of Medical Cannabis
P.O. Box 64882
St. Paul, MN 55164-0882
Comments must be submitted by Friday, Oct. 16.
Minnesota's Medical Cannabis Program currently covers more than a dozen qualifying conditions, including certain types of cancer, glaucoma, HIV/AIDS, intractable pain, and others.
Patients pay an annual fee to participate in the program, and may purchase liquid, pill, topical or vaporized delivery forms of cannabis from one of two approved manufacturers in the state.